HTG MOLECULAR DIAGNOSTICS, INC Annual Return On Equity in % from 2015 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Htg Molecular Diagnostics, Inc quarterly/annual Return On Equity history and growth rate from 2015 to 2022.
  • Htg Molecular Diagnostics, Inc Return On Equity for the quarter ending March 31, 2023 was -638 %, a 366% decline year-over-year.
  • Htg Molecular Diagnostics, Inc annual Return On Equity for 2022 was -369 %, a 225% decline from 2021.
  • Htg Molecular Diagnostics, Inc annual Return On Equity for 2021 was -113 %, a 3.31% increase from 2020.
  • Htg Molecular Diagnostics, Inc annual Return On Equity for 2020 was -117 %, a 21.1% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -369 -255 -225% Jan 1, 2022 Dec 31, 2022
2021 -113 +3.88 +3.31% Jan 1, 2021 Dec 31, 2021
2020 -117 -20.4 -21.1% Jan 1, 2020 Dec 31, 2020
2019 -96.8 -32.3 -50% Jan 1, 2019 Dec 31, 2019
2018 -64.5 -442 -117% Jan 1, 2018 Dec 31, 2018
2017 378 +1.92K Jan 1, 2017 Dec 31, 2017
2016 -1.54K -2.64K -240% Jan 1, 2016 Dec 31, 2016
2015 1.1K Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.